State-Pharma Deals for Hepatitis C Drugs Come Under Scrutiny

Several states have made alliances with pharma companies to eradicate hepatitis C infections. One of the more recent was between AbbVie and the state of Washington. Another is with Louisiana and Gilead Sciences’ subsidiary Asegua Therapeutics.